Results date and Investor events

RNS Number : 8387X

Inspiration Healthcare Group PLC

01 September 2022

 

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

Results date and Investor events  

Inspiration Healthcare Group plc (AIM:IHC), the global medical technology company , is pleased to announce that it will be publishing Interim Results for the six months ended 31^st  July 2022 on Tuesday 4^th October 2022.

An event for investors and shareholders will take place on Friday 7^th October, at the Company's new premises in Croydon, which is designed to give shareholders the opportunity to meet the senior management team at the Company's new state-of-the-art manufacturing and technology centre.  As well as a presentation of the interim results, guests will be able to see the enhanced research and development and manufacturing facilities as well as getting an update on the latest neonatal medical equipment. Details of this event and how to attend can be obtained from: [e-mail]

On Thursday 8^th September the Company is participating in the Cenkos Healthcare Capital Markets Day in London. This is an event for institutional investors to meet the senior management team of fast growing Healthcare companies and also an opportunity for Inspiration Healthcare to showcase its medical devices including the SLE600 ventilator and the Lifestart™ Neonatal bedside resuscitation unit.  No new trading information will be given at this event.

Enquiries:

Inspiration Healthcare Group plc Neil Campbell, Chief Executive Officer Jon Ballard, Chief Financial Officer	Tel: [phone]
Nominated Adviser & Broker Cenkos Securities plc Mark Connelly Stephen Keys Katy Birkin	Tel: [phone]
Cadogan PR  Alex Walters [e-mail]	Tel: [phone]

About Inspiration Healthcare Group

www.inspirationhealthcaregroup.plc.uk

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in critical care & operating theatres. The Company provides high-quality, innovative products to patients around the world which help to improve patient outcomes, and it actively invests in innovative product opportunities and disruptive technologies.

The Group currently consists of three companies: Inspiration Healthcare Ltd, SLE Ltd and Viomedex Ltd and under these brands the Group sells neonatal intensive care and operating theatre equipment around the work through a network of distributors into over 75 countries.  Products range from highly sophisticated capital equipment through to single use disposables all that can help improve outcomes of extremely sick patients.

In the UK and Ireland the Group offers direct sales for most of its products supported by Technical Service offering on site and return to base repair and maintenance along with 24/7 emergency hire of equipment and long term lease arrangements for its own brand products.  The Group also acts as a distributor for 3rd party companies that wish to access the NHS using the Group's sales and service expertise and knowledge of the NHS

The Group invests in growth through Research and Development holding numerous patents on its technology and has strong links with academic Key Opinion Leaders around the world and supports clinical research in the field of neonatal intensive care.

Further information on Inspiration Healthcare Group plc can be seen at  www.inspirationhealthcaregroup.plc.uk  

 

END

 

 

NORBKDBKOBKDKFN